Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Theralase Technologies Temettü
Temettü kriter kontrolleri 0/6
Theralase Technologies does not have a record of paying a dividend.
Anahtar bilgiler
n/a
Temettü verimi
n/a
Ödeme oranı
Sektör ortalama getirisi | 1.7% |
Bir sonraki temettü ödeme tarihi | n/a |
Eski temettü tarihi | n/a |
Hisse başına temettü | n/a |
Hisse başına kazanç | -CA$0.018 |
Temettü verim tahmini | n/a |
Son temettü güncellemeleri
Güncelleme yok
Recent updates
Is Theralase Technologies (CVE:TLT) In A Good Position To Deliver On Growth Plans?
Jul 29We're Not Very Worried About Theralase Technologies' (CVE:TLT) Cash Burn Rate
Apr 08Here's Why We're Not Too Worried About Theralase Technologies' (CVE:TLT) Cash Burn Situation
Dec 24Here's Why We're Not Too Worried About Theralase Technologies' (CVE:TLT) Cash Burn Situation
Sep 03Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: Insufficient data to determine if TLT's dividends per share have been stable in the past.
Büyüyen Temettü: Insufficient data to determine if TLT's dividend payments have been increasing.
Piyasaya Karşı Temettü Getirisi
Theralase Technologies Piyasaya Karşı Temettü Getirisi |
---|
Segment | Temettü Verimi |
---|---|
Şirket (TLT) | n/a |
Pazarın Alt %25'i (CA) | 1.7% |
Pazarın En İyi %25'i (CA) | 5.8% |
Sektör Ortalaması (Medical Equipment) | 1.7% |
Analist tahmini (TLT) (3 yıla kadar) | n/a |
Önemli Temettü: Unable to evaluate TLT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Yüksek Temettü: Unable to evaluate TLT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: Insufficient data to calculate TLT's payout ratio to determine if its dividend payments are covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as TLT has not reported any payouts.